Scancell Holdings (SCLP) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Sep 2013 03:06 PM
RNS
Investor Day
03 Sep 2013 07:00 AM
RNS
DNA ImmunoBody Patent Granted in first market
20 Aug 2013 07:00 AM
RNS
Inclusion on Frankfurt Stock Exchange
12 Aug 2013 05:16 PM
RNS
Director/PDMR Shareholding
08 Aug 2013 03:15 PM
RNS
Holding(s) in Company
05 Aug 2013 02:17 PM
RNS
Holding(s) in Company
01 Aug 2013 11:39 AM
RNS
Result of General Meeting
26 Jul 2013 07:00 AM
RNS
Result of Open Offer
23 Jul 2013 07:00 AM
RNS
Director/PDMR Shareholding
19 Jul 2013 04:40 PM
RNS
Second Price Monitoring Extn
19 Jul 2013 04:35 PM
RNS
Price Monitoring Extension
12 Jul 2013 07:00 AM
RNS
Research Update
10 Jul 2013 10:55 AM
RNS
Annual Financial Report
09 Jul 2013 07:00 AM
RNS
Proposed Firm Placing and Open Offer
09 Jul 2013 07:00 AM
RNS
Final Results
09 Apr 2013 07:00 AM
RNS
Appointment of Non-Executive Director
14 Mar 2013 07:00 AM
RNS
Re: The Journal of Clinical Investigation Paper
27 Feb 2013 02:00 PM
RNS
Directorate Change
06 Feb 2013 07:00 AM
RNS
ImmunoBody patent approved for grant in Japan
31 Jan 2013 07:00 AM
RNS
Half Yearly Report
29 Jan 2013 07:00 AM
RNS
Update on patient recruitment in clinical trial
12 Dec 2012 07:00 AM
RNS
Directorate Change
12 Dec 2012 07:00 AM
RNS
SCIB1 Trial-Higher Dose Allowed in Phase 1/2 Trial
06 Dec 2012 07:00 AM
RNS
Update on SCIB1 Phase 1/2 clinical trial
03 Dec 2012 09:30 AM
RNS
Holding(s) in Company
07 Nov 2012 04:02 PM
RNS
Result of AGM
12 Oct 2012 07:00 AM
RNS
Final Results
08 Oct 2012 10:43 AM
RNS
Holding(s) in Company
08 Oct 2012 10:43 AM
RNS
Holding(s) in Company
08 Oct 2012 10:31 AM
RNS
Notice of Results and Share Price Movement
03 Oct 2012 03:30 PM
RNS
Change of Advisers
10 Sep 2012 11:10 AM
RNS
Holding(s) in Company
03 Sep 2012 05:39 PM
RNS
Holding(s) in Company
23 Aug 2012 07:00 AM
RNS
Holding(s) in Company
20 Aug 2012 04:03 PM
RNS
Holding(s) in Company
20 Aug 2012 04:01 PM
RNS
Market Update
17 Aug 2012 09:24 AM
RNS
Holding(s) in Company
15 Aug 2012 01:12 PM
RNS
Moditope Vaccine Technology Platform
19 Jun 2012 07:00 AM
RNS
Long Term Treatment Approval
25 May 2012 07:00 AM
RNS
Vesting of Ichor Options
02 May 2012 07:00 AM
RNS
SCIB1 Update
17 Apr 2012 07:00 AM
RNS
SCIB1 Trial Update
16 Apr 2012 11:34 AM
RNS
Holding(s) in Company
13 Mar 2012 08:23 AM
RNS
Notice of Investor Meeting
09 Mar 2012 07:00 AM
RNS
Patent Approval
29 Feb 2012 03:49 PM
RNS
Change of Registered Office
31 Jan 2012 07:00 AM
RNS
Half Year Results
13 Dec 2011 04:28 PM
PRN
Issue of Equity
17 Nov 2011 11:29 AM
PRN
Holdings in Company
04 Nov 2011 07:00 AM
PRN
Confirmation of GBP2.85 million payment

Scancell Holdings PLC is a biopharmaceutical company that develops vaccines and other therapies to treat cancer and infectious diseases. Scancell's research focuses on the human immune system and how to use it to develop new treatments. Scancell uses four technology platforms to develop its products: ImmunoBody, Moditope, GlyMab and AvidiMab.

Scancell was founded in 1997 based on research led by Professor Lindy Durrant at the University of Nottingham.

Scancell Holdings PLC is listed on the London Stock Exchange (LSE) as SCLP.

Scancell share price listed at 8p in 2010.

UK 100

Latest directors dealings